Cromwell Holdings’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.58K Buy
43
+3
+8% +$363 ﹤0.01% 678
2026
Q1
$6.54K Buy
40
+13
+48% +$2K ﹤0.01% 605
2025
Q4
$4.7K Hold
27
﹤0.01% 616
2025
Q3
$3.89K Hold
27
﹤0.01% 638
2025
Q2
$2.72K Buy
+27
New +$2.06K ﹤0.01% 652

Other funds holding INSM

Cromwell Holdings's INSM Position: Q2 2026 in Review

Cromwell Holdings increased its Insmed (INSM) stake by 7.5% in Q2 2026, buying an estimated $363 and bringing the position to 43 shares worth $4.58K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Cromwell Holdings first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.54K in Q1 2026. 94 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cromwell Holdings held 43 shares of Insmed worth $4.58K as of Q2 2026.
  • Cromwell Holdings bought 3 Insmed shares in Q2 2026, an estimated $363.
  • Insmed made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #678 holding.
  • Cromwell Holdings first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Cromwell Holdings's Insmed position peaked at $6.54K in Q1 2026.
  • 94 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.